Today: 9 June 2026
Lloyds Share Price Today: LLOY Rises Before Q1 Results as Motor Finance Risk Lingers
28 April 2026
2 mins read

Lloyds Share Price Today: LLOY Rises Before Q1 Results as Motor Finance Risk Lingers

London, April 28, 2026, 11:49 BST

Lloyds Banking Group shares gained roughly 0.9% by late morning in London on Tuesday, trading near 98.4 pence ahead of the bank’s first-quarter results due Wednesday. According to delayed data, shares started the session at 98.15p, slipped to 96.91p, then climbed as high as 98.44p. Monday’s close stood at 97.50p, giving the lender a market cap around £57.5 billion.

Lloyds stands out as a straightforward play on UK consumers, mortgages, and deposit margins. IG Senior Technical Analyst Axel Rudolph flagged net interest income, credit quality, and the broader macro picture as key points for the update from “the UK’s largest domestic lender.” He argued Lloyds looks “well positioned” if interest rates remain high and credit quality stays intact, but warned a “sharp slowdown” would do damage. IG

Lloyds’ consensus, drawn from 18 analyst models, puts first-quarter statutory profit before tax at £1.84 billion, with net income seen at £4.80 billion. The banking net interest margin sits at 3.15%. That margin—essentially, the spread between income on loans and securities and costs on deposits and funding—is measured against interest-earning assets.

Lloyds Banking Group is set to release its Q1 interim management statement at 7 a.m. Wednesday. CFO William Chalmers will present at 9:30 a.m. For now, traders are making moves ahead of the announcement—today’s rise looks like positioning, not a reaction to the results.

Lloyds was in the market, snapping up its own stock. The bank disclosed in a Monday regulatory filing that it purchased 10.9 million ordinary shares on April 27, paying a volume-weighted average price of 97.8985p as part of its ongoing buyback programme. The shares are set to be cancelled, trimming the overall share count.

The picture remains messy. Late Monday, Reuters said consumer group Consumer Voice launched a legal challenge against the Financial Conduct Authority’s £9.1 billion motor-finance redress scheme, arguing the plan “fails to deliver fair” redress. The FCA labeled the challenge “disappointing” and cautioned it might hold up compensation and keep uncertainty hanging over the process. Reuters

On April 2, Lloyds issued an RNS stating it “does not currently believe” it needs to adjust its motor-finance provision after going through the FCA’s final rules. The bank did, however, point to lingering uncertainties—response rates, litigation, operating costs. Lloyds plans to provide further updates to investors when it reports first-quarter results. London South East

That peer context comes back to conduct risk. Over the weekend, Reuters said Close Brothers and Santander would not be contesting the FCA scheme, aligning with Barclays, and Lloyds had already chosen not to go to court. With those decisions, industry resistance narrows, but a fresh consumer challenge on Monday keeps the dispute alive.

The focus for Wednesday is tight: margin, impairments, and the exact language on redress. Impairments—provisions for loans that might go bad—are key. Any uptick would chip away at the higher-rate income narrative that’s been propping up Lloyds shares.

Stock Market Today

  • Cotton Futures Hold Steady Amid Mixed Trading and Market Moves
    June 9, 2026, 9:23 AM EDT. Cotton futures showed mixed performance on Monday with 5 to 15 point gains in most contracts, except July which fell 25 points by midday. The US dollar index declined to 99.94, while crude oil prices rose by 79 cents. Weekly Commodity Futures Trading Commission (CFTC) data revealed speculative funds reduced their net long positions in cotton by 1,798 contracts to 52,402 as of June 2. The Seam reported sales of 1,311 bales at 74.00 cents per pound, while the Cotlook A Index dropped 135 points to 86.15 cents on Friday. ICE certified cotton stocks increased by 11,219 bales to 261,648 on June 5. Key futures: July cotton at 73.5 cents (down 25), December 77.59 (up 11), March 78.85 (up 5). This reflects cautious market sentiment amid variable data.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 28.04.2026

UPS Earnings Beat Wall Street, But Amazon Pullback Is the Real Test
Next Story

UPS Earnings Beat Wall Street, But Amazon Pullback Is the Real Test

Go toTop